Sabater Juan A. 4

What Happened

Juan A. Sabater, a director of Harmony Biosciences (HRMY), received a derivative award on 2026-05-14 covering 21,872 shares (reported price $0.00). This filing reports an award/grant (transaction code A) — no cash was paid and no shares were sold or exercised in this transaction. The award is subject to vesting and is not immediately exercisable or marketable.

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (timely filing).
• Reported price: $0.00 (derivative grant/award).
• Shares/options granted: 21,872.
• Vesting: The option vests in full on the earlier of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service.
• Shares owned after transaction: Not disclosed in this filing.
• Transaction type: Award/Grant (A); not an exercise or sale.

Context

This was a compensation-style option grant to a director — a common non-cash award meant to align long-term interests, not an open-market purchase or sale. Because it vests over time and requires continued service, it does not reflect an immediate change in market exposure.